Journal
ENDOCRINOLOGY AND METABOLISM
Volume 35, Issue 2, Pages 272-287Publisher
KOREAN ENDOCRINE SOC
DOI: 10.3803/EnM.2020.35.2.272
Keywords
Growth hormone; Dwarfism; pituitary; Hypopituitarism; Hormone replacement therapy
Categories
Funding
- Korean Endocrine Society
Ask authors/readers for more resources
Growth hormone (GH) deficiency is caused by congenital or acquired causes and occurs in childhood or adulthood. GH replacement therapy brings benefits to body composition, exercise capacity, skeletal health, cardiovascular outcomes, and quality of life. Before initiating GH replacement, GH deficiency should be confirmed through proper stimulation tests, and in cases with proven genetic causes or structural lesions, repeated GH stimulation testing is not necessary. The dosing regimen of GH replacement therapy should be individualized, with the goal of minimizing side effects and maximizing clinical improvements. The Korean Endocrine Society and the Korean Society of Pediatric Endocrinology have developed a position statement on the diagnosis and treatment of GH deficiency. This position statement is based on a systematic review of evidence and expert opinions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available